|
[Related PubMed/MEDLINE]
Total Number of Papers: 2657
|
|
|
| |
|
[Display Entries]
|
|
>> all entries
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2023 |
Association of RB1 rs9568036 and CDKN1A rs1801270 Polymorphisms with Retinoblastoma Susceptibility. |
SNPs |
| 2 |
2023 |
New phase therapeutic pursuits for targeted drug delivery in glioblastoma multiforme. |
GBM, PI3K, RAS, RTK |
| 3 |
2023 |
Plakophilin 3 facilitates G1/S phase transition and enhances proliferation by capturing RB protein in the cytoplasm and promoting EGFR signaling. |
phospho-RB, PKP3 |
| 4 |
2023 |
Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression. |
ncRNAs |
| 5 |
2023 |
Sequential targeting of retinoblastoma and DNA synthesis pathways is a therapeutic strategy for sarcomas that can be monitored in real-time. |
PET |
| 6 |
2023 |
SETDB1 modulates degradation of phosphorylated RB and anti-cancer efficacy of CDK4/6 inhibitors. |
ASO, pRB |
| 7 |
2023 |
The role of EZH2 as a potential therapeutic target in retinoblastoma. |
EZH2, IHC |
| 8 |
2022 |
A case of retinoblastoma resulting in phthisis bulbi after proton beam radiation therapy. |
PBRT |
| 9 |
2022 |
A descriptive neuroimaging study of retinoblastoma in children: magnetic resonance imaging features. |
MRI |
| 10 |
2022 |
A Narrative Review - Therapy Options and Therapy Failure in Retinoblastoma. |
--- |
| 11 |
2022 |
A Proposal for Future Modifications on Clinical TNM Staging System of Retinoblastoma Based on the American Joint Committee on Cancer Staging Manual, 7th and 8th Editions. |
AJCC, C-index |
| 12 |
2022 |
A short-term chick embryo in vivo xenograft model to study retinoblastoma cancer stem cells. |
CE-CAM, CSCs, EGFP |
| 13 |
2022 |
ADAM10 and ADAM17-Novel Players in Retinoblastoma Carcinogenesis. |
ADAM, CAM, KD |
| 14 |
2022 |
Addition of intravitreal carboplatin with melphalan for management of vitreous seeding in retinoblastoma. |
IViC, RD |
| 15 |
2022 |
Advanced glycation end products induce senescence of atrial myocytes and increase susceptibility of atrial fibrillation in diabetic mice. |
AF, AGEs, AP, APD, DM |
| 16 |
2022 |
Advances in the research of plant-derived natural products against retinoblastoma. |
--- |
| 17 |
2022 |
AFAP1 antisense RNA 1 promotes retinoblastoma progression by sponging microRNA miR-545-3p that targets G protein subunit beta 1. |
AFAP1-AS1, CCK-8, GNB1, RIP, RT-qPCR |
| 18 |
2022 |
Altered Expression of RB and pRB in Tissue Arrays of Primary Breast Cancers and Matched Axillary Lymph Node Metastases. |
BC, LM, pRB |
| 19 |
2022 |
An atypical clinical/radiological presentation of Retinoblastoma in a 4-year-old child: A case report & educational lessons from Syria. |
--- |
| 20 |
2022 |
AN IN VIVO STUDY OF INTRAVITREAL RANIBIZUMAB FOLLOWING SUBRETINAL INOCULATION OF RB CELLS IN RABBITS EYES. |
--- |
| 21 |
2022 |
An overview of CDK3 in cancer: clinical significance and pharmacological implications. |
CDK3, E2F, EGFR, RAS |
| 22 |
2022 |
Analysis of Cause-Specific Mortality in Patients with Retinoblastoma. |
--- |
| 23 |
2022 |
Anatomo-Clinical Aspects of Retinoblastoma: A Series of 144 Cases. |
--- |
| 24 |
2022 |
Anemia and Bone Marrow Suppression After Intra-Arterial Chemotherapy in Children With Retinoblastoma: A Retrospective Analysis. |
IAC |
| 25 |
2022 |
Anterior chamber enhancement predicts optic nerve infiltration in retinoblastoma. |
AC, GBCA, GS, ON |
| 26 |
2022 |
Applications of Non-Coding RNAs in Patients With Retinoblastoma. |
ncRNAs |
| 27 |
2022 |
Aqueous humor as a surrogate biomarker for retinoblastoma tumor tissue. |
AH, cfDNA |
| 28 |
2022 |
Atypical spindle cell/pleomorphic lipomatous tumor with a sarcomatous component showing high mitotic activity and Ki-67 labeling index: report of a unique case mimicking dedifferentiated liposarcoma. |
ASPLT, CDK4, LI, MDM2 |
| 29 |
2022 |
beta-asarone attenuates the proliferation, migration and enhances apoptosis of retinoblastoma through Wnt/beta-catenin signaling pathway. |
--- |
| 30 |
2022 |
Bilateral enucleation for retinoblastoma: A study of 14 patients. |
--- |
| 31 |
2022 |
Bioinformatics Analysis and Experimental Identification of Immune-Related Genes and Immune Cells in the Progression of Retinoblastoma. |
IRGs, LCP1, MDSCs, SH3 |
| 32 |
2022 |
Characterizing DNA methylation signatures of retinoblastoma using aqueous humor liquid biopsy. |
AH, cfDNA |
| 33 |
2022 |
Chemotherapy modulates CDK4/6 inhibitors resistance in metastatic breast cancer by Rb1 mutations: a case report and literature review. |
HER2, HR |
| 34 |
2022 |
CIGB-300 Peptide Targets the CK2 Phospho-Acceptor Domain on Human Papillomavirus E7 and Disrupts the Retinoblastoma (RB) Complex in Cervical Cancer Cells. |
--- |
| 35 |
2022 |
CircRNA-Associated CeRNAs Regulatory Axes in Retinoblastoma: A Systematic Scoping Review. |
ceRNA, circRNAs |
| 36 |
2022 |
circRNF20 aggravates the malignancy of retinoblastoma depending on the regulation of miR-132-3p/PAX6 axis. |
circRNAs, circRNF20, PAX6, TNM |
| 37 |
2022 |
Circ_0075804 Regulates the Expression of LASP1 by Targeting miR-1287-5p and Thus Affects the Biological Process of Retinoblastoma. |
circRNA, LASP1, RT-qPCR |
| 38 |
2022 |
Clinical Characteristics and Image Manifestations of a Rare Retinoblastoma with a Bone Metastasis. |
NSE |
| 39 |
2022 |
Clinical Presentation of Retinoblastoma in Ethiopia: A Case of Jimma University Medical Center Pediatric Oncology Unit, Southwest Ethiopia. |
JUMC |
| 40 |
2022 |
Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges. |
--- |
| 41 |
2022 |
Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven Cancers. |
HPV |
| 42 |
2022 |
Complex translocation leading to13q interstitial deletion in a Moroccan child with retinoblastoma and intellectual disability. |
--- |
| 43 |
2022 |
Conformational buffering underlies functional selection in intrinsically disordered protein regions. |
E1A |
| 44 |
2022 |
Coordinating gene expression during the cell cycle. |
CDK, FOXM1, TFs |
| 45 |
2022 |
Cordycepin inhibited the retinoblastoma cell proliferation, migration, and invasion as well as lung metastasis via modulating c-Myc/cyclin D1 pathway. |
--- |
| 46 |
2022 |
Correlation of clinical and radiological predictors of retinoblastoma with high-risk histopathological features. |
HRFs |
| 47 |
2022 |
Deconstructing ADAURA: It is Time to Forgo Adjuvant Platinum-Based Chemotherapy in Resected IB-IIIA EGFR+ NSCLC (Except with RB Alterations?) When Adopting Adjuvant Osimertinib. |
DFS, EGFR, NSCLC |
| 48 |
2022 |
Detection and Diagnosis of Retinoblastoma: Can Mobile Devices Be the Next Step Toward Early Intervention? |
--- |
| 49 |
2022 |
Determining the Incidence of Retinoblastoma and Survival Rate of Retinoblastoma Patients in Puerto Rico using the Cancer Registry of Puerto Rico (1985-2012). |
--- |
| 50 |
2022 |
Development and characterization of DNA aptamer against Retinoblastoma by Cell-SELEX. |
--- |
| 51 |
2022 |
Development of alpha-Tocopherol Succinate-Based Nanostructured Lipid Carriers for Delivery of Paclitaxel. |
alpha-TS, PTX |
| 52 |
2022 |
Diagnostic accuracy of B-scan in predicting retinoblastoma in children, taking Magnetic Resonance Imaging of orbits as gold standard. |
MRI |
| 53 |
2022 |
Diffusion-Weighted MR Imaging of the Optic Nerve Can Improve the Detection of Post-Laminar Optic Nerve Invasion from Retinoblastoma. |
ADC, AUC, CI, DWI, PLONI, ROC |
| 54 |
2022 |
Disruption of Multiple Overlapping Functions Following Stepwise Inactivation of the Extended Myc Network. |
DKO, MEFs, MycKO |
| 55 |
2022 |
Dopachrome tautomerase is a retinoblastoma-specific gene, and its proximal promoter is preferentially active in human retinoblastoma cells. |
DCT |
| 56 |
2022 |
Dual-Target Multifunctional Superparamagnetic Cationic Nanoliposomes for Multimodal Imaging-Guided Synergistic Photothermal/Photodynamic Therapy of Retinoblastoma. |
CN, ICG, PDT, PFH, PTT |
| 57 |
2022 |
E2F1/CKS2/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma. |
CKS2 |
| 58 |
2022 |
Emerging therapeutic targets for retinoblastoma. |
CSCs |
| 59 |
2022 |
Emodin-8-O-beta-D-glucopyranoside, a natural hydroxyanthraquinone glycoside from plant, suppresses cancer cell proliferation via p21-CDKs-Rb axis. |
CDKs, EG |
| 60 |
2022 |
Enhanced Epithelial-to-Mesenchymal Transition and Chemoresistance in Advanced Retinoblastoma Tumors Is Driven by miR-181a. |
EMT |
| 61 |
2022 |
Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer. |
AR, CRPC, high-T, PCa, PDX |
| 62 |
2022 |
Exploration of retinoblastoma pathogenesis with bioinformatics. |
CCK-8, DEGs, GSEA |
| 63 |
2022 |
Expression and therapeutic targeting of BMI1 in canine gliomas. |
BMI1 |
| 64 |
2022 |
Farrerol exhibits inhibitory effects on lung adenocarcinoma cells by activating the mitochondrial apoptotic pathway. |
LAC |
| 65 |
2022 |
FGF19 Is Coamplified With CCND1 to Promote Proliferation in Lung Squamous Cell Carcinoma and Their Combined Inhibition Shows Improved Efficacy. |
LUSC |
| 66 |
2022 |
Five-Year Experience in Treatment of Retinoblastoma with Intra-Arterial Chemotherapy: A Single-Center Analysis. |
IAC |
| 67 |
2022 |
Fluorometholone inhibits high glucose-induced cellular senescence in human retinal endothelial cells. |
DR, FML, HRECs, IL-6, IL-8, SA-beta-gal, TF, TNF-alpha, VEGF |
| 68 |
2022 |
Genetic testing in adult survivors of retinoblastoma in Denmark: A study of the experience and impact of genetic testing many years after initial diagnosis. |
--- |
| 69 |
2022 |
Genome maintenance in retinoblastoma: Implications for therapeutic vulnerabilities. |
RB1 |
| 70 |
2022 |
Germline RB1 Mutation in Retinoblastoma Patients: Detection Methods and Implication in Tumor Focality. |
NGS |
| 71 |
2022 |
Gilteritinib Enhances Anti-Tumor Efficacy of CDK4/6 Inhibitor, Abemaciclib in Lung Cancer Cells. |
FDA |
| 72 |
2022 |
Glioma targeted therapy: insight into future of molecular approaches. |
EGFR |
| 73 |
2022 |
Growth Inhibition of Retinoblastoma Cell Line by Exosome-Mediated Transfer of miR-142-3p. |
mRNAs, TME |
| 74 |
2022 |
GSDME Increases Chemotherapeutic Drug Sensitivity by Inducing Pyroptosis in Retinoblastoma Cells. |
GSDME |
| 75 |
2022 |
Health-Related Quality of Life in Adolescent and Young Adult Retinoblastoma Survivors. |
AYAs, HRQoL |
| 76 |
2022 |
Hematologic Complications Associated With Intra-arterial Chemotherapy for Retinoblastoma Treatment: A Single Institution Experience. |
IAC |
| 77 |
2022 |
Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies. |
iPSC, OBs, OS |
| 78 |
2022 |
Highly Efficient Photodynamic Therapy with Mitochondria-Targeting Aggregation-Induced Emission Photosensitizer for Retinoblastoma. |
AIE, PDI, PDT, PS |
| 79 |
2022 |
Histopathologic and genetic findings in atypical spindle cell/pleomorphic lipomatous tumors and atypical pleomorphic fibromas. |
aCGH, ASPLT, PF |
| 80 |
2022 |
hsa_circ_0084811 Regulates Cell Proliferation and Apoptosis in Retinoblastoma through miR-18a-5p/miR-18b-5p/E2F5 Axis. |
circRNAs, E2F5, miR-18a-5p, miR-18b-5p |
| 81 |
2022 |
Identification of Epigenetically Modified Hub Genes and Altered Pathways Associated With Retinoblastoma. |
--- |
| 82 |
2022 |
Identification of novel genes by targeted exome sequencing in Retinoblastoma. |
--- |
| 83 |
2022 |
Implementing the WHO Global Initiative for Childhood Cancer in Morocco: Survival study for the six indexed childhood cancers. |
ALL, BL, GICC, WHO |
| 84 |
2022 |
Improving Medical Students' Awareness About Retinoblastoma: A Practical Strategy. |
--- |
| 85 |
2022 |
Induction of autophagy-dependent ferroptosis to eliminate drug-tolerant human retinoblastoma cells. |
MDR |
| 86 |
2022 |
Integrated Analysis of Cancer Tissue and Vitreous Humor from Retinoblastoma Eyes Reveals Unique Tumor-Specific Metabolic and Cellular Pathways in Advanced and Non-Advanced Tumors. |
--- |
| 87 |
2022 |
Integrated analysis of multiple bioinformatics studies to identify microRNA-target gene-transcription factor regulatory networks in retinoblastoma. |
DEGs, DEMs, GEO, GO, KEGG, miRNAs, RRA, TFs |
| 88 |
2022 |
Interleukin-11 (IL11) inhibits myogenic differentiation of C2C12 cells through activation of extracellular signal-regulated kinase (ERK). |
CAC, ERK, IL-11, MHC |
| 89 |
2022 |
Intravitreal chemotherapy-induced cataract in retinoblastoma: challenges and outcome. |
--- |
| 90 |
2022 |
Knockdown of the Long Noncoding RNA TUG1 Suppresses Retinoblastoma Progression by Disrupting the Epithelial-Mesenchymal Transition. |
EMT, lncRNA, qPCR, RTCA, TUG1 |
| 91 |
2022 |
Kruppel-like factor 2 acts as a tumor suppressor in human retinoblastoma. |
ChIP, CXCR4, KLF2, MMP-9, PCNA |
| 92 |
2022 |
Kruppel-like transcription factor 16 transcriptional up-regulation of cellular retinoic acid-binding proteins-2 promotes the invasion and migration and inhibits apoptosis of retinoblastoma cells by regulating integrin-beta1/focal adhesion kinase /extracellular signal-regulated kinase pathway. |
ChIP, CRABP2, ERK, FAK, KLF16, MTT, RT-qPCR |
| 93 |
2022 |
Lack of complete response pretransplant is not associated with inferior overall survival for stage 4a metastatic retinoblastoma. |
CR, IFRT, MSKCC, OS, PR, VGPR |
| 94 |
2022 |
Legumain affects the PI3K/AKT tumor progression pathway in retinoblastoma. |
LGMN, LGMN-OE, NCOE, RCVRN |
| 95 |
2022 |
LINC00488 Induces Tumorigenicity in Retinoblastoma by Regulating microRNA-30a-5p/EPHB2 Axis. |
--- |
| 96 |
2022 |
Liquid biopsy in Retinoblastoma: A review. |
cfDNA, ctDNA |
| 97 |
2022 |
LncRNA HOTAIR facilitates proliferation and represses apoptosis of retinoblastoma cells through the miR-20b-5p/RRM2/PI3K/AKT axis. |
lncRNA |
| 98 |
2022 |
LncRNA MEG3 attenuates the malignancy of retinoblastoma cells through inactivating PI3K /Akt/mTOR signaling pathway. |
lncRNA |
| 99 |
2022 |
LncRNA MIR17HG promotes the proliferation, migration, and invasion of retinoblastoma cells by up-regulating HIF-1alpha expression via sponging miR-155-5p. |
CCK-8, HIF-1alpha, lncRNA, miR-155-5p, MIR17HG, qRT-PCR |
| 100 |
2022 |
LncRNA ZFPM2-AS1 Enhances Retinoblastoma Development by Targeting the miR-3612/NT5E Signaling Axis. |
miR, NT5E, ZFPM2 |
|
A Search Service for Abbreviation / Long Form
